The report details the company's business operations for the fiscal year 2012, highlighting its commitment to sustainable growth and socially responsible practices. The report outlines Daiichi Sankyo's Third Mid-term Business Management Plan (FY2013-2017), which includes plans for enhancing its product portfolio and R&D pipeline, expanding into emerging markets, and transitioning to a low-cost operating framework. It also highlights the company's efforts in promoting environmental management, ethical business practices, and diversity and inclusion within its workforce. Additionally, the report emphasizes the company's dedication to healthcare access and its contributions to global health through the development of new medicines, provision of low-priced medicines, and technical support in developing countries.
Go back to company
Daiichi Sankyo Co Ltd 2013 Value Report
Issuing Company Daiichi Sankyo Co., Ltd.
Report Type Sustainability Report
Report Language EN
Report Filesize 7.77 MB
No. of Pages 100 pages
Reporting periodApril 1, 2012-March 31, 2013
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards Unknown
Materiality Assessmenttrue